Search
-
Ipsos launches GLP-1 PersonaBot, designed to support companies’ understanding of the consumer obesity treatment market
Ipsos’ latest AI-powered innovation offers unparalleled insights into the fast-moving consumer obesity treatment market – while reinforcing Ipsos’ position at the forefront of AI applications in market research.
-
Healthcare vs Evolution: Can GLP-1s Rewrite Our Evolutionary Story?
Our evolutionary tale began 6 million years ago, when humans were programmed to hoard calories in a world of scarcity. Today, that ancient wiring has become our greatest health risk.
-
Ipsos Answers Esomar’s Questions to help online research buyers
The primary aim of the ESOMAR's Questions is to increase transparency and raise awareness of the key issues for researchers to consider when deciding whether an online sampling approach is fit for their purpose.
-
Discover Ipsos CX Advisory
Unlock the full potential of your Customer Experience and drive tangible business results with Ipsos CX Advisory.
-
Getting Started With Mystery Shopping
Discover Ipsos’s key ingredient to your CX and commercial success
-
CX Global Insights 2025: Unlocking the Future of Customer Experience
Elevate Your CX Strategy with Data-Driven Insights
-
CX Signals GenAI: Unlock deeper CX insights by leveraging unfiltered customer sentiment on social media and reviews
Harness the power of social media and reviews to help improve your Customer Experience (CX).
-
Lead Saves: Convert ‘lost’ leads into revenue
Drive up sales conversion by understanding and converting customers you thought were ‘lost’.
-
Bringing Healthcare Segmentations to Life: The Dawn of the GenAI-Powered Persona
Enter the age of generative AI, ushering in a new era of possibility with the advent of the persona bot – a tool with the potential to revolutionise how pharmaceutical companies activate and leverage segmentation data.